Reader Poll

POLL: Draft classification criteria for SLE stir controversy

Publish date: August 3, 2017

 


Recommended Reading

Cutaneous manifestations can signify severe systemic disease in ANCA-associated vasculitis
MDedge Dermatology
SLE linked to subsequent risk of malignant melanoma
MDedge Dermatology
CC-220 shows efficacy, safety concerns in phase II SLE trial
MDedge Dermatology
FDA approves first specific treatment for giant cell arteritis
MDedge Dermatology
Study confirms new mutation, possible therapeutic target in epidermolysis bullosa
MDedge Dermatology
VIDEO: Troponin acts as atherosclerotic biomarker in patients with lupus
MDedge Dermatology
TWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitis
MDedge Dermatology
New classification system for systemic lupus erythematosus moves forward
MDedge Dermatology
Self-injectable belimumab receives FDA approval for systemic lupus erythematosus
MDedge Dermatology
When the painful ‘bumps’ are calciphylaxis, what’s next?
MDedge Dermatology